Ostatní
Návod 
Becton, Dickinson and Company
BDX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
51.0B
Obrat
22B
Zisk
2B
Aktiva
55B
Dluh
19B
ROE
0%
ROA
0%
PE
25
PS
2
Cena 1R
162-252
⌀ Cena
187.22
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
09-02-2026
Poslední dividenda
10-03-2026
Profil
Becton, Dickinson and Company vyvíjí, vyrábí a prodává zdravotnický materiál, přístroje, laboratorní zařízení a diagnostické přípravky pro zdravotnické instituce, lékaře, výzkumné pracovníky v biologických vědách, klinické laboratoře, farmaceutický průmysl a širokou veřejnost po celém světě. BD Medical segment společnosti nabízí periferní intravenózní (IV) a pokročilé periferní katétry, centrální vedení, katétry pro akutní dialýzu, produkty pro vaskulární péči a přípravu, bezjehlové IV konektory a nástavce, zařízení pro přenos léků v uzavřeném systému, detekce nebezpečných léků, hypodermické injekční stříkačky a jehly, anesteziologické jehly a podnosy, enterální stříkačky a systémy odstraňování ostrých předmětů; IV systémy pro podávání léků a infuzní terapie, systémy pro pracovní postupy při komponování léků, systémy automatizovaného dávkování a řízení dodávek léků a systémy pro optimalizace a sledování léků; kroužky, jehly do pera a další výrobky pro léčbu cukrovky; a předplnitelné systémy podávání léků. Jeho segment BD Life Sciences poskytuje vzorky a produkty pro odběr krve; automatizovanou kultivaci krve a tuberkulózy, molekulární testování, identifikaci mikroorganismů a citlivost na léky a systémy cytologie na bázi tekutin, jakož i rychlé diagnostické testy, mikrobiologické laboratorní automatizační produkty a pokovené mediální produkty; a fluorescenčně aktivované buněčné třídiče a analyzátory, protilátky a sestavy, reagenční systémy a řešení pro jednobuněčnou analýzu exprese genů, jakož i klinickou onkologii, imunologické a transplantační diagnostické/monitorovací činidla a analyzátory. BD Intervenční segment společnosti nabízí reparaci kýly a měkkých tkání, biologické a biologicky resorbovatelné štěpy, biochirurgie a další chirurgické produkty; prostředky pro prevenci chirurgických infekcí, chirurgické a laparoskopické nástroje; periferní intervenční produkty; urologii a produkty pro kritickou péči. Společnost byla založena v roce 1897 a sídlí ve Franklin Lakes v New Jersey.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
70000
Založení
1973-02-21
Podobné společnosti
$ 83.48
+ $ 0.09
$ 202.89
- $ 0.78
$ 863.20
+ $ 8.55
$ 74.07
+ $ 0.10
$ 248.57
- $ 2.92
$ 146.16
- $ 0.58
$ 294.08
- $ 0.79
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 21.92 | 21.84 | 20.18 | 19.37 | 18.87 | 20.25 | 17.12 | 17.29 | 15.98 | 12.09 | 12.48 | 10.28 | 8.45 | 8.05 | 7.71 | 7.83 | 7.37 | |
| Cost of Revenues | 11.89 | 11.92 | 11.05 | 11.20 | 10.39 | 10.82 | 9.54 | 9.00 | 8.72 | 6.15 | 6.49 | 5.59 | 4.15 | 3.88 | 3.76 | 3.74 | 3.54 | |
| Gross Profit | 10.03 | 9.92 | 9.13 | 8.17 | 8.48 | 9.43 | 7.58 | 8.29 | 7.26 | 5.94 | 5.99 | 4.70 | 4.30 | 4.17 | 3.95 | 4.09 | 3.83 |
| Revenue | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 5.25 | 5.89 | 5.51 | 5.27 | 5.17 | 5.44 | 4.99 | 5.05 | 4.71 | 5.09 | |
| Cost of Revenues | 2.91 | 3.09 | 2.88 | 3.02 | 2.93 | 2.92 | 2.68 | 2.74 | 2.68 | 3.39 | |
| Gross Profit | 2.34 | 2.80 | 2.63 | 2.26 | 2.24 | 2.52 | 2.31 | 2.30 | 2.03 | 1.70 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 1.24 | 1.26 | 1.34 | 1.10 | 1.06 | 1.01 | 0.77 | 0.83 | 0.63 | 0.55 | 0.49 | 0.47 | 0.48 | 0.43 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 4.72 | 4.71 | 4.87 | 4.33 | 4.33 | 4.02 | 2.93 | 3.01 | 2.56 | 2.15 | 2.42 | 1.92 | 1.85 | 1.72 | |
| Depreciation & Amortization | 2.47 | 2.46 | 2.29 | 2.16 | 2.32 | 2.37 | 2.49 | 2.78 | 1.98 | 1.09 | 1.11 | 0.89 | 0.56 | 0.55 | 0.51 | 0.50 | 0.50 | |
| Total Operating Expenses | 7.32 | 7.35 | 6.73 | 5.75 | 6.00 | 6.44 | 5.78 | 6.05 | 5.02 | 4.11 | 3.83 | 3.20 | 2.70 | 2.92 | 2.40 | 2.33 | 2.15 | |
| Operating Income | 2.72 | 2.58 | 2.40 | 2.11 | 2.28 | 2.80 | 1.48 | 1.76 | 1.50 | 1.48 | 1.43 | 1.07 | 1.61 | 1.25 | 1.56 | 1.76 | 1.68 |
| Operating Income | TTM | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.28 | ||
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.14 | ||
| Depreciation & Amortization | 0.61 | 0.63 | 0.62 | 0.61 | 0.61 | 0.44 | 0.57 | 0.57 | 0.56 | 0.46 | ||
| Total Operating Expenses | 1.75 | 2.10 | 1.75 | 1.71 | 1.78 | 1.70 | 1.71 | 1.57 | 1.59 | 1.22 | ||
| Operating Income | 0.59 | 0.70 | 0.88 | 0.55 | 0.45 | 0.82 | 0.60 | 0.73 | 0.44 | 0.35 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.02 | 0.04 | 0.16 | 0.05 | 0.02 | 0.01 | 0.01 | 0.01 | 0.07 | 0.08 | 0.02 | 0.02 | 0.05 | 0.04 | 0.05 | 0.04 | 0.04 | |
| Interest Expense | 0.57 | 0.61 | 0.53 | 0.45 | 0.40 | 0.47 | 0.53 | 0.64 | 0.71 | 0.52 | 0.39 | 0.37 | 0.14 | 0.14 | 0.13 | 0.08 | 0.05 | |
| Other Expense | -0.66 | -0.70 | -0.39 | -0.45 | -0.50 | -0.56 | -0.50 | -0.60 | -0.43 | -0.41 | -0.72 | -0.41 | 0.01 | 0.01 | 0.00 | -0.01 | 0.00 | |
| IBT | 2.06 | 1.88 | 2.01 | 1.66 | 1.78 | 2.24 | 0.99 | 1.16 | 1.17 | 0.98 | 1.07 | 0.74 | 1.52 | 1.17 | 1.47 | 1.72 | 1.66 | |
| Income Tax Expense | 0.31 | 0.20 | 0.30 | 0.13 | 0.15 | 0.15 | 0.11 | -0.06 | 0.86 | -0.12 | 0.10 | 0.04 | 0.34 | 0.24 | 0.36 | 0.45 | 0.48 | |
| Net Income | 1.76 | 1.68 | 1.71 | 1.48 | 1.78 | 2.09 | 0.87 | 1.22 | 0.31 | 1.10 | 0.98 | 0.70 | 1.19 | 1.29 | 1.17 | 1.27 | 1.32 |
| Net Income | TTM | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.06 | 0.05 | 0.03 | 0.03 | 0.01 | ||
| Interest Expense | 0.11 | 0.16 | 0.15 | 0.15 | 0.16 | 0.16 | 0.14 | 0.13 | 0.11 | 0.11 | ||
| Other Expense | -0.11 | -0.19 | -0.18 | -0.18 | -0.15 | -0.28 | -0.10 | -0.10 | -0.08 | -0.17 | ||
| IBT | 0.49 | 0.51 | 0.70 | 0.36 | 0.31 | 0.54 | 0.50 | 0.63 | 0.36 | 0.18 | ||
| Income Tax Expense | 0.11 | 0.02 | 0.13 | 0.06 | 0.00 | 0.12 | 0.01 | 0.10 | 0.08 | 0.03 | ||
| Net Income | 0.38 | 0.49 | 0.57 | 0.31 | 0.30 | 0.42 | 0.49 | 0.54 | 0.28 | 0.11 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $5.88 | $4.97 | $5.93 | $6.92 | $2.75 | $3.96 | $0.62 | $4.70 | $4.59 | $3.43 | $6.13 | $6.63 | $5.59 | $5.75 | $5.62 | |
| EPS Diluted | $0.00 | $0.00 | $5.86 | $4.94 | $5.88 | $6.85 | $2.71 | $3.89 | $0.60 | $4.60 | $4.49 | $3.35 | $5.99 | $6.49 | $5.59 | $5.62 | $5.49 | |
| Shares Outstanding | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.28 | 0.27 | 0.26 | 0.22 | 0.21 | 0.20 | 0.19 | 0.20 | 0.21 | 0.22 | 0.23 | |
| Diluted Shares Outstanding | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.28 | 0.27 | 0.26 | 0.22 | 0.22 | 0.21 | 0.20 | 0.20 | 0.21 | 0.23 | 0.24 |
| Per Share Data | TTM | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.45 | $1.68 | $1.85 | $0.97 | $0.37 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.45 | $1.68 | $1.85 | $0.96 | $0.37 | ||
| Shares Outstanding | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | ||
| Diluted Shares Outstanding | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 |
| Current Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 4.49 | 0.85 | 1.72 | 1.42 | 1.01 | 2.28 | 2.83 | 0.54 | 1.14 | 14.18 | 1.54 | 1.42 | 1.86 | 1.89 | 1.67 | 1.18 | 1.22 | |
| Short Term Investments | 0.85 | 0.01 | 0.45 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 | 0.04 | 0.37 | 0.10 | 0.88 | 0.72 | 0.51 | 0.39 | 0.53 | |
| Total Cash & ST Investments | 5.34 | 0.86 | 2.16 | 1.42 | 1.01 | 2.30 | 2.85 | 0.57 | 1.16 | 14.22 | 1.91 | 1.52 | 2.75 | 2.61 | 2.18 | 1.56 | 1.74 | |
| Accounts Receivable | 2.60 | 2.99 | 3.03 | 2.53 | 2.19 | 2.50 | 2.40 | 2.34 | 2.32 | 1.74 | 1.62 | 1.62 | 1.19 | 1.24 | 1.25 | 1.23 | 1.21 | |
| Inventory | 3.26 | 3.89 | 3.84 | 3.27 | 3.22 | 2.87 | 2.74 | 2.58 | 2.45 | 1.82 | 1.72 | 1.96 | 1.50 | 1.40 | 1.24 | 1.24 | 1.15 | |
| Other Current Assets | 1.02 | 1.51 | 1.43 | 1.45 | 1.71 | 1.07 | 0.89 | 1.11 | 1.48 | 0.00 | 0.00 | 0.00 | 0.70 | 0.62 | 0.65 | 0.63 | 0.41 | |
| Total Current Assets | 12.21 | 9.26 | 10.47 | 8.68 | 8.14 | 8.84 | 8.97 | 6.64 | 7.41 | 18.63 | 6.37 | 6.05 | 6.13 | 5.87 | 5.32 | 4.67 | 4.51 |
| Current Assets | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 0.85 | 0.74 | 0.67 | 0.71 | 1.72 | 4.46 | 2.35 | 1.18 | 1.42 | 0.92 | |
| Short Term Investments | 0.01 | 0.02 | 0.02 | 0.02 | 0.45 | 0.85 | 0.83 | 0.00 | 0.01 | 0.01 | |
| Total Cash & ST Investments | 0.86 | 0.76 | 0.68 | 0.73 | 2.16 | 5.31 | 3.18 | 1.18 | 1.42 | 0.93 | |
| Accounts Receivable | 2.99 | 2.94 | 3.03 | 2.64 | 3.03 | 2.60 | 2.56 | 2.27 | 2.53 | 2.41 | |
| Inventory | 3.89 | 3.95 | 3.72 | 3.86 | 3.84 | 3.26 | 3.23 | 3.30 | 3.27 | 3.59 | |
| Other Current Assets | 1.51 | 1.35 | 1.23 | 1.43 | 1.43 | 1.05 | 1.38 | 1.40 | 1.45 | 1.66 | |
| Total Current Assets | 9.26 | 9.00 | 8.67 | 8.66 | 10.47 | 12.21 | 10.34 | 8.16 | 8.68 | 8.59 |
| Long-Term Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 6.52 | 7.00 | 6.82 | 7.07 | 6.01 | 6.39 | 5.92 | 5.66 | 5.38 | 4.64 | 3.90 | 4.06 | 3.61 | 3.48 | 3.30 | 3.21 | 3.10 | |
| Goodwill | 24.55 | 33.02 | 26.47 | 24.52 | 24.62 | 23.90 | 23.62 | 23.38 | 23.60 | 7.56 | 7.42 | 7.54 | 1.09 | 1.11 | 1.08 | 0.99 | 0.76 | |
| Intangible Assets | 9.91 | 2.99 | 10.92 | 10.95 | 12.31 | 12.78 | 13.81 | 14.98 | 16.44 | 5.89 | 6.35 | 7.39 | 1.13 | 1.21 | 1.16 | 1.12 | 0.79 | |
| Long-Term Investments | 5.28 | 0.00 | 0.00 | 0.00 | 0.00 | -5.23 | -5.75 | -5.68 | -5.74 | 0.04 | 0.80 | 1.12 | 0.00 | 0.00 | 0.00 | -225.88 | -149.98 | |
| Other Long-Term Assets | -6.95 | 3.06 | 2.62 | 1.56 | -3.36 | 1.95 | 1.69 | 1.08 | 1.08 | 0.97 | -0.93 | 0.67 | 0.50 | 0.49 | 0.50 | 0.44 | 0.49 | |
| Total Long-Term Assets | 43.38 | 46.07 | 46.82 | 44.10 | 44.79 | 45.03 | 45.04 | 45.20 | 46.49 | 19.10 | 19.22 | 20.78 | 6.32 | 6.28 | 6.04 | 5.76 | 5.15 | |
| Total Assets | 55.58 | 55.33 | 57.29 | 52.78 | 52.93 | 53.87 | 54.01 | 51.84 | 53.90 | 37.73 | 25.59 | 26.82 | 12.45 | 12.15 | 11.36 | 10.43 | 9.65 |
| Long-Term Assets | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 7.00 | 6.82 | 6.65 | 6.60 | 6.82 | 6.52 | 6.59 | 6.65 | 6.56 | 6.47 | |
| Goodwill | 33.02 | 26.60 | 26.44 | 26.33 | 26.47 | 24.55 | 24.57 | 24.60 | 24.52 | 24.58 | |
| Intangible Assets | 2.99 | 9.79 | 10.13 | 10.49 | 10.92 | 9.91 | 10.26 | 10.61 | 10.95 | 11.31 | |
| Long-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -4.58 | -4.37 | |
| Other Long-Term Assets | 3.06 | 2.70 | 2.58 | 2.59 | 2.62 | 2.40 | 2.40 | 2.26 | 2.08 | 2.06 | |
| Total Long-Term Assets | 46.07 | 45.91 | 45.80 | 46.01 | 46.82 | 43.38 | 43.82 | 44.12 | 44.10 | 44.43 | |
| Total Assets | 55.33 | 54.90 | 54.47 | 54.67 | 57.29 | 55.58 | 54.16 | 52.27 | 52.78 | 53.02 |
| Current Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.96 | 0.00 | 1.90 | 1.64 | 1.70 | 1.79 | 1.36 | 1.09 | 1.11 | 0.80 | 0.67 | 0.63 | 0.40 | 0.33 | 0.35 | 0.30 | 0.33 | |
| Short-Term Debt | 1.19 | 1.56 | 2.17 | 1.14 | 2.18 | 0.50 | 0.71 | 1.31 | 2.60 | 0.20 | 1.00 | 1.45 | 0.20 | 0.21 | 0.41 | 0.23 | 0.20 | |
| Other Current Liabilities | 0.00 | 6.75 | 4.72 | 3.72 | 3.93 | 6.13 | 5.12 | 4.29 | 3.17 | 2.17 | 0.19 | 0.00 | 0.00 | 1.57 | 1.22 | 1.27 | 1.11 | |
| Current Liabilities | 6.61 | 8.31 | 8.96 | 6.64 | 7.81 | 6.63 | 5.82 | 5.60 | 7.22 | 3.34 | 4.40 | 4.39 | 2.24 | 2.13 | 1.98 | 1.82 | 1.67 |
| Current Liabilities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 0.00 | 6.35 | 0.00 | 6.35 | 1.90 | 0.00 | 0.00 | 0.00 | 1.64 | 5.02 | |
| Short-Term Debt | 1.56 | 1.81 | 1.60 | 1.32 | 2.17 | 1.19 | 2.02 | 2.02 | 1.14 | 1.86 | |
| Other Current Liabilities | 6.75 | 0.00 | 6.09 | 0.00 | 4.72 | 5.41 | 5.31 | 5.52 | 3.72 | 0.00 | |
| Current Liabilities | 8.31 | 8.16 | 7.69 | 7.66 | 8.96 | 6.61 | 7.33 | 7.54 | 6.64 | 6.88 |
| Long-Term Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 18.13 | 17.62 | 17.94 | 15.15 | 13.89 | 17.11 | 17.22 | 18.08 | 18.89 | 18.67 | 10.55 | 11.37 | 3.77 | 3.76 | 3.76 | 2.48 | 1.50 | |
| Capital Leases | 0.91 | 0.00 | 0.00 | 1.02 | 0.88 | 1.23 | 1.44 | 1.27 | 1.06 | 0.00 | 1.32 | 0.00 | 0.00 | 0.00 | 0.00 | 1,068.48 | 899.11 | |
| Def. Tax Liability | 0.00 | 0.00 | 0.00 | 0.00 | 5.06 | 5.23 | 5.76 | 5.71 | 5.74 | 1.61 | 1.68 | 2.77 | 0.38 | 0.41 | 0.26 | 0.23 | 0.15 | |
| Total Liabilities | 29.71 | 29.94 | 31.40 | 26.98 | 27.63 | 30.19 | 30.24 | 30.67 | 32.91 | 24.79 | 17.95 | 19.66 | 7.39 | 7.11 | 7.23 | 5.60 | 4.22 |
| Long-Term Liabilities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 17.62 | 17.53 | 17.67 | 17.44 | 17.94 | 18.13 | 16.00 | 14.09 | 14.74 | 14.93 | |
| Capital Leases | 0.00 | 0.91 | 0.00 | 0.94 | 0.00 | 0.00 | 0.00 | 0.89 | 1.02 | 0.90 | |
| Def. Tax Liability | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.45 | 4.37 | |
| Total Liabilities | 29.94 | 29.43 | 29.23 | 29.46 | 31.40 | 29.71 | 28.51 | 26.94 | 26.98 | 27.08 |
| Total Common Equity | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.37 | 0.00 | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | 0.35 | 0.35 | 0.35 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | |
| Retained Earnings | 16.02 | 0.00 | 16.14 | 15.54 | 15.16 | 13.83 | 12.79 | 12.91 | 12.60 | 13.11 | 12.73 | 12.31 | 12.11 | 11.34 | 10.44 | 9.63 | 8.72 | |
| Comprehensive Income | -1.56 | 0.00 | -1.73 | -1.53 | -1.49 | -2.09 | -2.55 | -2.28 | -1.91 | -1.72 | -1.93 | -1.74 | -1.00 | -0.52 | -0.80 | -0.67 | -0.46 | |
| Total Common Equity | 25.87 | 25.39 | 25.89 | 25.80 | 25.30 | 23.68 | 23.78 | 21.18 | 20.99 | 12.95 | 7.63 | 7.17 | 5.05 | 5.04 | 4.14 | 4.83 | 5.43 |
| Total Common Equity | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.00 | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | |
| Retained Earnings | 0.00 | 16.43 | 16.15 | 16.14 | 16.14 | 16.02 | 15.80 | 15.54 | 15.54 | 15.69 | |
| Comprehensive Income | 0.00 | -1.81 | -1.72 | -1.68 | -1.73 | -1.58 | -1.54 | -1.52 | -1.55 | -1.51 | |
| Total Common Equity | 25.39 | 25.47 | 25.24 | 25.20 | 25.89 | 25.87 | 25.65 | 25.33 | 25.80 | 25.94 |
| Other | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 19.32 | 19.18 | 20.11 | 15.88 | 16.07 | 17.61 | 17.93 | 19.39 | 21.50 | 18.87 | 11.55 | 12.82 | 3.97 | 3.97 | 4.17 | 2.72 | 1.70 | |
| Book Value | 25.87 | 25.39 | 25.89 | 25.80 | 25.30 | 23.68 | 23.78 | 21.18 | 20.99 | 12.95 | 7.63 | 7.17 | 5.05 | 5.04 | 4.14 | 4.83 | 5.43 |
| Other | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book Value | 25.39 | 25.47 | 25.24 | 25.20 | 25.89 | 25.87 | 25.65 | 25.33 | 25.80 | 25.94 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.46 | 1.68 | 1.71 | 1.53 | 1.78 | 2.09 | 0.87 | 1.22 | 0.31 | 1.10 | 0.98 | 0.70 | 1.19 | 0.93 | 1.11 | 1.26 | 1.18 | |
| Depreciation & Amortization | 2.29 | 2.46 | 2.29 | 2.29 | 2.23 | 2.27 | 2.15 | 2.25 | 1.98 | 1.09 | 1.11 | 0.89 | 0.56 | 0.55 | 0.51 | 0.50 | 0.50 | |
| Stock-Based Compensation | 0.25 | 0.26 | 0.25 | 0.26 | 0.23 | 0.24 | 0.24 | 0.26 | 0.32 | 0.17 | 0.20 | 0.17 | 0.11 | 0.10 | 0.09 | 0.07 | 0.08 | |
| Change Working Capital | 0.12 | -0.80 | 0.29 | -0.83 | -1.39 | 0.28 | 0.51 | -0.14 | 0.90 | -0.37 | 0.40 | 0.27 | -0.12 | 0.16 | 0.00 | -0.25 | -0.07 | |
| Change In Accounts Receivable | -0.44 | 0.07 | -0.45 | -0.29 | 0.03 | -0.10 | -0.05 | -0.05 | -0.17 | -0.09 | -0.13 | 0.00 | -0.01 | 0.00 | -0.03 | -0.03 | -0.07 | |
| Change In Accounts Payable | -0.23 | -0.19 | 0.63 | -0.52 | -0.47 | 0.69 | 0.21 | -0.47 | 0.87 | 0.13 | 0.37 | 0.15 | 0.20 | 0.37 | 0.02 | 0.00 | 0.00 | |
| Change In Inventories | -0.02 | -0.41 | 0.10 | -0.02 | -0.63 | -0.10 | -0.13 | -0.15 | 0.25 | -0.05 | 0.07 | 0.20 | -0.19 | -0.15 | -0.09 | -0.12 | -0.12 | |
| Other Non-cash Items | 2.71 | 0.31 | -0.52 | 0.36 | -0.09 | 0.07 | 0.06 | 0.12 | -0.40 | 0.80 | 0.30 | 0.04 | 0.03 | -0.26 | 0.03 | 0.10 | 0.03 | |
| Cash from Operations | 3.95 | 0.00 | 0.00 | 2.99 | 2.63 | 4.65 | 3.54 | 3.33 | 2.87 | 2.55 | 2.56 | 1.73 | 1.74 | 1.51 | 1.76 | 1.72 | 1.74 |
| Cash Flow From Operating Activities | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 0.38 | 0.49 | 0.55 | 0.33 | 0.30 | 0.42 | 0.49 | 0.54 | 0.28 | 0.15 | |
| Depreciation & Amortization | 0.61 | 0.63 | 0.57 | 0.65 | 0.61 | 0.44 | 0.57 | 0.57 | 0.56 | 0.59 | |
| Stock-Based Compensation | 0.00 | 0.06 | -0.24 | 0.15 | 0.09 | 0.00 | 0.05 | 0.06 | 0.08 | 0.06 | |
| Change Working Capital | -0.42 | 0.25 | 0.10 | -0.78 | -0.37 | 0.01 | 0.24 | -0.59 | 0.15 | 0.32 | |
| Change In Accounts Receivable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.80 | |
| Change In Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.23 | |
| Change In Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | |
| Other Non-cash Items | 0.05 | 0.15 | -0.17 | -0.08 | 0.21 | 0.21 | 0.07 | -0.01 | -0.15 | 0.41 | |
| Cash from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.33 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.72 | -0.76 | -0.73 | -0.87 | -0.97 | -1.23 | -0.81 | -0.96 | -0.90 | -0.73 | -0.72 | -0.63 | -0.65 | -0.59 | -0.55 | -0.61 | -0.63 | |
| Acquisitions | 0.54 | 0.00 | -3.92 | 0.54 | -2.07 | -0.51 | -0.16 | 0.48 | -14.75 | -0.01 | 0.16 | -8.41 | -0.04 | 0.60 | -0.10 | -0.49 | -0.02 | |
| Investments | -0.83 | 0.00 | -0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.90 | 0.73 | 0.00 | 0.63 | -0.17 | -0.23 | -0.14 | 514.78 | 0.96 | |
| Sales of Investment | 0.00 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.72 | 0.84 | 0.65 | -1.12 | 486.87 | 0.12 | 535.74 | |
| Other Investing Activities | -0.43 | 0.00 | 0.00 | -0.38 | -0.19 | -0.14 | -0.26 | -0.26 | -1.09 | -0.89 | -0.83 | -0.74 | -0.74 | 1.02 | -486.98 | -514.84 | -536.76 | |
| Cash from Investing | -1.44 | 0.00 | 0.00 | -0.72 | -3.23 | -1.88 | -1.23 | -0.74 | -15.83 | -0.88 | -0.67 | -8.32 | -0.95 | -0.31 | -0.90 | -1.04 | -0.71 |
| Cash Flow From Investing Activities | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.11 | -0.35 | -0.19 | -0.12 | -0.11 | -0.30 | -0.18 | -0.13 | -0.12 | -0.29 | |
| Acquisitions | 0.00 | 0.00 | -0.01 | 0.01 | -0.01 | -3.92 | 0.00 | 0.00 | 0.00 | 0.54 | |
| Investments | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.41 | -0.02 | -0.82 | 0.00 | 0.00 | |
| Sales of Investment | 0.00 | 0.00 | -0.41 | -0.41 | 0.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.11 | |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -3.81 | 0.00 | 0.00 | -0.72 | -0.81 | -5.11 | -5.15 | -4.74 | -4.00 | -3.98 | -0.75 | -0.01 | 0.00 | 0.00 | -0.04 | -0.03 | -0.20 | |
| Debt Issued | 6.36 | -0.93 | 4.23 | 0.54 | -0.74 | 4.79 | 3.69 | 2.64 | 6.62 | 11.30 | -0.52 | 8.86 | 0.00 | -0.20 | 1.49 | 1.06 | 1.90 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.87 | 2.92 | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 35.05 | 0.08 | 0.05 | |
| Repurchase of Common Stock | -0.50 | -1.00 | -0.50 | 0.00 | -0.50 | -1.75 | 3.39 | 2.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,500.00 | -1.50 | -0.75 | |
| Dividends Paid | -1.09 | 0.00 | 0.00 | -1.11 | -1.08 | -1.05 | -1.03 | -0.98 | -0.93 | -0.68 | -0.56 | -0.49 | -0.42 | -0.39 | -0.37 | -0.36 | -0.35 | |
| Other Financing Activities | -0.38 | 0.00 | 0.00 | -0.12 | 1.80 | -0.27 | -0.11 | -0.21 | 4.87 | 15.64 | -0.45 | 6.68 | -0.39 | -0.58 | 1,464.99 | 1.10 | 0.02 | |
| Cash from Financing | 0.97 | 0.00 | 0.00 | -1.96 | -0.59 | -3.31 | 0.02 | -3.22 | -0.06 | 10.98 | -1.76 | 6.19 | -0.81 | -0.97 | -0.37 | -0.71 | -1.22 |
| Cash Flow From Financing Activities | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.72 | |
| Debt Issued | 19.18 | -0.16 | 0.07 | 0.51 | -1.35 | 0.79 | 1.31 | 1.90 | 0.23 | -0.19 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Repurchase of Common Stock | -0.25 | -0.25 | 0.00 | 0.00 | -0.75 | 0.50 | 0.00 | 0.00 | -0.50 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.27 | |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.00 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 3.46 | -1.01 | 0.38 | 0.32 | -1.23 | -0.53 | 2.33 | -0.65 | -13.04 | 12.64 | 0.12 | -0.44 | -0.03 | 0.22 | 0.50 | -0.04 | -0.18 | |
| Closing Cash Balance | 4.49 | 0.85 | 1.86 | 1.48 | 1.16 | 2.39 | 2.92 | 0.59 | 1.14 | 14.18 | 1.54 | 1.42 | 1.86 | 1.89 | 1.67 | 1.18 | 1.22 |
| Cash position | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 0.17 | 0.05 | 0.05 | -0.07 | -1.04 | -2.63 | 2.09 | 1.16 | -0.25 | 0.46 | |
| Closing Cash Balance | 1.02 | 0.85 | 0.80 | 0.75 | 0.81 | 1.86 | 4.49 | 2.39 | 1.23 | 1.48 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 3.22 | 2.67 | 3.07 | 2.12 | 1.66 | 3.42 | 2.73 | 2.37 | 1.97 | 1.82 | 1.84 | 1.10 | 1.09 | 0.92 | 1.21 | 1.11 | 1.11 | |
| Real Free Cash Flow | 2.97 | 2.41 | 2.83 | 1.86 | 1.43 | 3.18 | 2.49 | 2.11 | 1.65 | 1.65 | 1.65 | 0.93 | 0.98 | 0.82 | 1.12 | 1.04 | 1.03 |
| Free Cash Flow | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.55 | 1.00 | 1.05 | 0.04 | 0.59 | 0.88 | 1.09 | 0.38 | 0.73 | 1.03 | |
| Real Free Cash Flow | 0.55 | 0.95 | 1.28 | -0.11 | 0.50 | 0.88 | 1.03 | 0.32 | 0.64 | 0.97 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 25 | 44.3 | 1703.4 |
| P/S | 2 | 2.6 | 67.9 |
| P/B | 1.7 | 2.4 | 25.8 |
| P/FCF | 16.5 | 23.9 | 396.3 |
| Market cap | $51.0 | $56.2 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 35.3 % | 0 % |
| Debt to Income | 1091.7 % | 1918.8 % | 0 % |
| Debt to Free cash flow | 719.5 % | 16.7 % | 0 % |
| Interest expense percentage | 20.8 % | 22.8 % | 0 % |
| Current ratio | 1.1 | 2 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 6.9 % | 12.4 % | 0 % |
| ROA | 3.2 % | 5.2 % | 0 % |
| CapEx to Revenue | 3.5 % | 5.9 % | 0 % |
| RaD to Revenue | 0 % | 5.6 % | 0 % |
| ROEM | 304,486.1 | 242222.8 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 45.8 % | 47.8 % | 0 % |
| Operating margin | 12.4 % | 14.1 % | 0 % |
| Net margin | 8 % | 10.2 % | 0 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 2.5 % | 0 % |
| Dividend payout percentage | 0 % | 63.4 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 285.1 mil | 249.1 mil |
| Employee count | 72.0 tis | 39.4 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
